Introduction to Imbruvica (Ibrutinib) 140mg
Brutini (Ibrutinib) 140mg is a targeted prescription medicine used in the treatment of certain blood cancers, including chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and Waldenström’s macroglobulinemia. This medicine belongs to a specialized group of oncology drugs that block cancer growth signals while strengthening immune response.
Brutini (Ibrutinib) 140mg is classified under Prescription Medicines, Oncology Medicines, Targeted Cancer Therapies, and Oral Anticancer Drugs. It contains Ibrutinib, which works by inhibiting specific proteins that help cancer cells grow and survive.
In global markets, Imbruvica is the original brand of Ibrutinib, offering similar therapeutic benefits when prescribed by a qualified healthcare professional.
What Is Imbruvica (Ibrutinib) 140mg?
Imbruvica is the original brand name for Ibrutinib, an oral targeted therapy widely used in hematologic (blood-related) cancers. Ibrutinib belongs to a class of medicines known as Bruton’s Tyrosine Kinase (BTK) inhibitors.
These medicines block signals that cancer cells need to grow and multiply. Generic versions such as Brutini 140mg contain the same active compound and may be used depending on physician recommendation and regional availability.
Drug Class and Mechanism of Action
How Ibrutinib Works
It works in several ways:
- Blocks Bruton’s Tyrosine Kinase (BTK), a key protein in cancer cell survival
- Interrupts cancer cell signaling pathways
- Slows down the growth and spread of malignant cells
Through these mechanisms, Ibrutinib helps control cancer progression and improve patient outcomes.
How Imbruvica Works in the Body
Certain blood cancers rely on signaling pathways to survive. Imbruvica disrupts these pathways and weakens cancer cells.
Key Actions of Ibrutinib
- Inhibits B-cell receptor signaling
- Reduces survival of abnormal lymphocytes
- Enhances immune-mediated destruction of cancer cells
Generic options such as Brutini deliver the same active compound for effective targeted therapy when prescribed appropriately.
Medical Uses of Imbruvica (Ibrutinib) 140mg
Imbruvica for Chronic Lymphocytic Leukemia (CLL)
Imbruvica is commonly used in patients with CLL.
Potential Benefits
- Prolonged progression-free survival
- Reduced lymph node enlargement
- Improved overall response rates
Imbruvica for Mantle Cell Lymphoma (MCL)
Treatment Benefits
- Effective in relapsed or refractory cases
- Slows disease progression
- Improves survival outcomes
Imbruvica for Waldenström’s Macroglobulinemia
Benefits
- Reduces abnormal protein levels
- Improves blood viscosity symptoms
- Enhances quality of life
Who Can Take Brutini 140mg?
Because Ibrutinib is a potent targeted therapy, it should be used under medical supervision.
Eligibility Criteria
Patients may be prescribed Imbruvica if they:
- Are diagnosed with CLL, MCL, or related conditions
- Require targeted therapy
- Can undergo regular monitoring
Who Should Avoid Imbruvica (Ibrutinib) 140mg
Imbruvica should NOT be used by:
- Pregnant women or those planning pregnancy
- Patients with severe bleeding disorders
- Individuals with hypersensitivity to Ibrutinib
Imbruvica (Ibrutinib) 140mg Dosage and Administration
Standard Dosage Guidelines
Typical dosage includes:
- Ibrutinib 140mg capsules taken orally
- Dose may vary depending on indication
- Taken once daily with water
- Can be taken with or without food
Dosage Adjustments
Doctors may adjust the dose based on:
- Liver function
- Side effects such as bleeding or infections
- Drug interactions
Side Effects of Imbruvica 140mg
Common Side Effects
- Diarrhea
- Fatigue
- Muscle and joint pain
- Bruising
Serious Side Effects
- Bleeding complications
- Heart rhythm problems (atrial fibrillation)
- Severe infections
Patients should report any unusual symptoms immediately.
Storage: Store below 25°C in a dry place, away from moisture and sunlight. Keep out of reach of children.
Frequently Asked Questions (FAQs)
1. Is Imbruvica (Ibrutinib) 140mg chemotherapy?
No, it is a targeted therapy (BTK inhibitor), not traditional chemotherapy.
2. How long is treatment continued?
Treatment is usually long-term, depending on response and tolerance.
3. Can Brutini 140mg cure cancer?
It helps control the disease but may not provide a complete cure.
4. Can it be taken at home?
Yes, it is an oral medication taken at home under doctor supervision.
5. Can pregnant women take Brutini 140mg?
No, it is unsafe during pregnancy.
6. Is Brutini 140mg the same as Imbruvica?
Yes, Brutini contains Ibrutinib, the same active ingredient as Imbruvica.
7. Is a prescription required?
Yes, it is a prescription-only medicine.
Medical Disclaimer
Disclaimer: This content is for informational purposes only and not medical advice. Imbruvica (Ibrutinib) must be used under medical supervision. Always consult your doctor before treatment.
